244 related articles for article (PubMed ID: 19688153)
1. Antiviral therapy in children with hydroa vacciniforme.
Lysell J; Wiegleb Edström D; Linde A; Carlsson G; Malmros-Svennilson J; Westermark A; Andersson J; Wahlgren CF
Acta Derm Venereol; 2009; 89(4):393-7. PubMed ID: 19688153
[TBL] [Abstract][Full Text] [Related]
2. Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.
Pahlow Mose A; Fisker N; Clemmensen O; Bygum A
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422336
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
4. The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.
Ozçay F; Arslan H; Bilezikçi B; Sevmiş S; Moray G; Haberal M
Transplant Proc; 2009 Sep; 41(7):2878-80. PubMed ID: 19765462
[TBL] [Abstract][Full Text] [Related]
5. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.
Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D
Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
Xu Z; Lian S
Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
[TBL] [Abstract][Full Text] [Related]
8. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells.
Tanaka C; Hasegawa M; Fujimoto M; Iwatsuki K; Yamamoto T; Yamada K; Kawa K; Saikawa Y; Toga A; Mase S; Wada T; Takehara K; Yachie A
Br J Dermatol; 2012 Jan; 166(1):216-8. PubMed ID: 21729029
[No Abstract] [Full Text] [Related]
11. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated hydroa vacciniforme-like lymphoproliferative syndrome: excellent response to antiviral therapy.
İmren IG; Demirkan N; Çomut E; Duygulu Ş
Int J Dermatol; 2020 Dec; 59(12):e452-e454. PubMed ID: 32808321
[No Abstract] [Full Text] [Related]
13. Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy.
Sunde PT; Olsen I; Enersen M; Grinde B
J Clin Virol; 2008 Jun; 42(2):176-8. PubMed ID: 18304869
[TBL] [Abstract][Full Text] [Related]
14. Hydroa vacciniforme-like lymphoma in a patient from the Brazilian Amazon.
Santos M; Nogueira L; Talahri C; Massone C; Cerroni L; Mira MT; Talhari S
Int J Dermatol; 2013 May; 52(5):641-3. PubMed ID: 22512805
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir.
Walling DM; Flaitz CM; Nichols CM
J Infect Dis; 2003 Sep; 188(6):883-90. PubMed ID: 12964120
[TBL] [Abstract][Full Text] [Related]
16. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity.
Höllsberg P; Kusk M; Bech E; Hansen HJ; Jakobsen J; Haahr S
Acta Neurol Scand; 2005 Dec; 112(6):395-402. PubMed ID: 16281923
[TBL] [Abstract][Full Text] [Related]
17. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
18. Hydroa vacciniforme with mucosal involvement and recalcitrant periodontitis and multiple virus re-activators after sun-exposure.
Nishizawa A; Satoh T; Takayama K; Yokozeki H
Acta Derm Venereol; 2010 Sep; 90(5):498-501. PubMed ID: 20814626
[TBL] [Abstract][Full Text] [Related]
19. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
Chen CC; Chang KC; Medeiros LJ; Lee JY
J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
[TBL] [Abstract][Full Text] [Related]
20. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
Chen CC; Chang KC; Medeiros LJ; Lee JY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
